1 citations
,
June 2013 in “Science-business Exchange” In this study, researchers at the University of Pennsylvania found that increasing FGF9 levels in wounded mouse skin can lead to the growth of hair follicles.
1 citations
,
May 2013 in “PubMed” This review discusses the classification of female androgenic alopecia using the Ludwig classification and details the hair growth cycle but provides no new clinical results.
1 citations
,
January 1996 It's hard to tell male pattern baldness from other types because symptoms can be similar.
1 citations
,
June 1990 in “PubMed” This study in Chinese patients with male pattern baldness found that 2% minoxidil solution led to moderate hair growth in 22% of participants and was generally well-tolerated.
1 citations
,
March 1990 in “Clinical Drug Investigation” 2% topical minoxidil can help reduce hair loss and promote hair growth in male pattern baldness.
January 2026 in “Archives of Dermatological Research” July 2025 in “Clinical and Experimental Dermatology” This study concludes that in men, telogen effluvium (TE) precedes androgenetic alopecia (AGA), with anagen shortening occurring before follicle miniaturization.
June 2024 in “Dermatology and therapy” This study reviewed recent advancements in using botulinum toxin for treating androgenetic alopecia and emphasized the need for further research to determine the most effective injection sites and depths, as current strategies show inconsistent results.
April 2024 in “Human genomics” This study identified MPB susceptibility genes and potential drug candidates that may help uncover molecular mechanisms and address male-pattern baldness.
January 2024 in “International Ayurvedic medical journal” This study explores how Ayurveda concepts, specifically Prakruti, relate to male pattern baldness, suggesting that individual constitutional types may predict susceptibility to earlier hair loss when influenced by modern lifestyle factors.
Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.
Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.
October 2012 in “Ain-Shams Journal of Surgery” This study found that inserting follicular units in a specific direction during hair restoration surgery did not improve natural-looking outcomes, as hair could be styled freely with regular combing.
Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.
January 2008 in “HAL (Le Centre pour la Communication Scientifique Directe)” This study identified complex regulatory elements and interactions involving the Hr gene and HR protein that are crucial for hair follicle formation and cycling in mammals.
May 2004 in “Dermatologic Surgery” In this study, 32% of men continued taking finasteride for androgenetic alopecia after 1 to 3 years, but only a small percentage reported hair growth.
January 1998 in “KAGAKU TO SEIBUTSU” The document suggests that male hormones likely affect hair growth and baldness, and future treatments might involve stem cells and androgen-independent cells.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review examined a polyherbal hair formulation aimed at managing male pattern baldness, reporting that its ingredients may enhance scalp blood circulation, strengthen hair follicles, and promote hair regrowth through various mechanisms such as antioxidant and DHT-inhibiting effects.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review examines a polyherbal hair oil formulation containing ingredients like Amla and Pumpkin seed oil, reporting potential benefits for managing male pattern baldness through antioxidant, anti-inflammatory, and DHT-inhibiting properties, alongside improved scalp blood circulation and hair regrowth.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review reports on a polyherbal hair formulation developed to manage male pattern baldness, highlighting its potential to enhance scalp blood circulation, strengthen hair follicles, and promote hair regrowth through antioxidant, anti-inflammatory, and DHT-inhibiting mechanisms.
This study reviews the use of natural products, like herbal extracts and essential oils, in treating male pattern baldness, noting their potential benefits compared to conventional therapies that may carry side effects or ethical concerns.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights a polyherbal hair formulation that combines various natural ingredients, reporting potential benefits in improving scalp circulation, strengthening hair, and promoting regrowth, which might offer a safer alternative for managing male pattern baldness compared to synthetic drugs.
Minoxidil and finasteride are recommended for male pattern baldness.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Minoxidil and finasteride are recommended for male pattern baldness.
May 2026 in “International Journal of Homoeopathic Sciences” In this case report, a 27-year-old woman with female pattern baldness experienced reduced hair fall and improved hair density after six months of individualized homeopathic treatment, supported by lifestyle guidance at Dr Batra’s® Homeopathy Clinic, with sustained benefits observed over an additional eight-month follow-up period.
May 2026 in “International Journal of Homoeopathic Sciences” In this case report, long-term classical homeopathic management of a woman with advanced female pattern baldness led to significant hair stabilization, improved scalp health, increased hair density, and notable psychosocial benefits, despite previous treatment failures.
February 2026 in “International Journal of Molecular Sciences” In this study, researchers identified 47 proteins associated with male pattern baldness severity and prioritized five candidate genes, including druggable CD38, suggesting new non-hormonal targets for therapeutic development.
January 2026 in “Medico Research Chronicles” This case report suggests that a classical homeopathic approach at Dr Batra’s® Homeopathy Clinic significantly improved hair fall, hair density, and quality of life for a young male with Grade III Male Pattern Baldness over 18 months.
January 2026 in “Dermatologic Therapy” This study found that a novel topical dutasteride lotion, FOL100, demonstrated excellent safety, tolerability, and usability with promising signs of clinical benefit for mild-to-moderate male pattern baldness.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study explores a novel hypothesis for Male Pattern Baldness, suggesting that chronic tension in the scalp's Galea Aponeurotica creates a hypoxic environment affecting hair follicles, and proposes a Triad Therapeutic Protocol to address this underlying cause rather than just the symptoms.